Sunday, April 14, 2024

CATEGORY

EFPIA

The Critical Role of Joint Clinical Assessment in Accelerating EU Access to New Therapies

A recent study underscores the critical need for detailed guidance on the European Union's Joint Clinical Assessment (JCA) process to enhance patient access to...

Simulation Study Reveals Challenges and Recommendations for EU Oncology Medicine Evaluations Under EUnetHTA21 Guidelines

In a groundbreaking simulation study, researchers delved into the ramifications of adopting the EUnetHTA21 methodologies for the evaluation of oncology medicines within the European...

EFPIA for the Pharmaceutical Industry Calls Collaborative Approach to EU Pharma Legislation Reforms

In a defining moment for the pharmaceutical industry within the European Union, the European Federation of Pharmaceutical Industries and Associations (EFPIA) has vocally addressed...

European Pharmaceutical Industry Raises Concerns Over Proposed Pharmaceutical Legislation’s Impact on Innovation and Competitiveness

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has conducted research shedding light on the potential consequences of the European Commission's draft Pharmaceutical...

Proposed Pharmaceutical Legislation Poses Risk of Europe Losing One-Third of Global R&D Share by 2040

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has raised concerns about the European Commission's draft Pharmaceutical Legislation and its potential impact on...

EFPIA Responds to EU Commission’s Measures to Tackle Medicine Shortages

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has issued a statement in response to the European Commission's Communication on addressing medicine shortages...

New Report Calls for Overhaul of European Cancer Services to Meet Future Deman

A recent report published on October 11th has emphasized the necessity for a comprehensive reevaluation of Europe's cancer services. The goal is to enhance...

Proposed PFAS Restriction Could Disrupt Medicine Manufacturing in Europe

A proposed restriction on the use of fluorinated substances and Polyfluoroalkyl Substances (PFAS), across the European Economic Area (EEA) is causing concern within the...

Latest news